HCA HCA Healthcare
Data as of close
Healthcare · Services-General Medical & Surgical Hospitals, Nec
HCA Healthcare (HCA) is a healthcare company in the Services-General Medical & Surgical Hospitals, Nec industry, with a market capitalization of $97.7 billion. Shares last traded at $467.78, 15.9% below their 52-week high. Over the past year the stock is up 0.2%. HCA trades at a price-to-earnings ratio of 14.42, above the Services-General Medical & Surgical Hospitals, Nec median of 8.23. Net profit margin is 8.6%, above the peer median of 4.8%. Revenue grew 7.1% year over year. The shares yield 0.7% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.
HCA Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $679M | $2.84 | 10% |
| 2024-12-31 | $690M | $2.64 | 12% |
| 2023-12-31 | $661M | $2.39 | 13% |
| 2022-12-31 | $653M | $2.22 | 12% |
| 2021-12-31 | $624M | $1.90 | 9% |
| 2020-12-31 | $153M | $0.45 | 4% |
| 2019-12-31 | $550M | $1.58 | 16% |
| 2018-12-31 | $487M | $1.37 | 13% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2026 | $7.27 | 2026-10-29 |
| Q2 2026 | $7.62 | 2026-07-28 |
| Q1 2026 | $7.15 | 2026-04-29 |
| Q4 2025 (derived) | $8.09 | 2026-02-10 |
| FY 2025 | $28.33 | 2026-02-10 |
| Q3 2025 | $6.96 | 2025-10-30 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Services-General Medical & Surgical Hospitals, Nec peers
HCA vs 6 industry peers (Services-General Medical & Surgical Hospitals, Nec), by market cap. Data as of close
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.